Skip to main navigation Skip to main content Skip to page footer

Precocious or delayed puberty

Clinical information

Puberty describes the phase of human development that leads to sexual and physical maturity. It begins with endocrine changes in the central nervous system.

At the onset of puberty, there is a pulsatile release of gonadotropin-releasing hormone (GnRH) in the hypothalamus. The production of GnRH subsequently leads to an increased secretion of luteinising hormone (LH) and gonadotropin (follicle-stimulating hormone, FSH), which in turn stimulate the production of oestrogens and androgens in the gonads. 

In girls, puberty usually begins a few years earlier than in boys. With the shift of hormones come multiple physical changes, which typically include a growth spurt and the development of underarm and pubic hair in both sexes. In young males the voice deepens and facial hair begins to grow. Young females experience an increase in fat mass, breast development and the menarche (the first period).

If these sexual characteristics develop before the age of approximately 9–12 years, this is referred to as precocious puberty. In contrast, if puberty starts after this age range, it is considered delayed.

Diagnostics

Puberty describes the phase of human development that leads to sexual and physical maturity. It begins with endocrine changes in the central nervous system.  

At the onset of puberty, there is a pulsatile release of gonadotropin-releasing hormone (GnRH) in the hypothalamus. The production of GnRH subsequently leads to an increased secretion of luteinising hormone (LH) and gonadotropin (follicle-stimulating hormone, FSH), which in turn stimulate the production of oestrogens and androgens in the gonads.  

In girls, puberty usually begins a few years earlier than in boys. With the shift of hormones come multiple physical changes, which typically include a growth spurt and the development of underarm and pubic hair in both sexes. In young males the voice deepens and facial hair begins to grow. Young females experience an increase in fat mass, breast development and the menarche (the first period). 

If these sexual characteristics develop before the age of approximately 9–12 years, this is referred to as precocious puberty. In contrast, if puberty starts after this age range, it is considered delayed.

Methods
Technology Parameter Substrate Species Calibration Ig Class Format Order No.
ELISA 17-OH-Progesterone ELISA
antibody-coated microplate wells 0/0.15/0.5/1.5/3/7.5/20 ng/ml 96 x 01
EQ 6163-9601
ChLIA IDS 17-OH Progesterone Streptavidin-coated magnetic particles quantitative
100 x 01
IS-51001
ChLIA IDS 17-OH Progesterone Control Set 2 x 1.0 ml Control 1/2/3 17-OH Progesterone 3 concentration levels
IS-51301
ChLIA IDS Total Testosterone Streptavidin-coated magnetic particles quantitative
100 x 01
IS-50001
ChLIA IDS Total Testosterone Control Set 2 x 1.0 ml Control 1/2/3 Testosterone 3 concentration levels
IS-50301
ELISA Androstenedione ELISA
antibody-coated microplate wells 0/0.1/0.3/1/3/10 ng/ml 96 x 01
EQ 6153-9601
ChLIA IDS Androstenedione Antibody-coated magnetic particles quantitative
100 x 01
IS-54001
ChLIA IDS Androstenedione Calibrator Set 1 x 1.0 ml Calibrator 1/2/3/4/5/6 Androstenedione 6 concentration levels
IS-54201
ChLIA IDS Androstenedione Control Set 2 x 1.0 ml Control 1/2 Androstenedione 2 concentration levels
IS-54301
ELISA Dehydroepiandrosterone (DHEA) ELISA
antibody-coated mircoplate wells quantitative 96 x 01
EQ 6154-9601-1
ChLIA IDS SHBG Streptavidin-coated magnetic particles quantitative
100 x 01
IS-56001
ChLIA IDS SHBG Control Set 2 x 1.0 ml Control 1/2/3 Sexual hormone-binding globulin (SHBG) 3 concentration levels
IS-56301
ELISA Estrone ELISA
antibody-coated microplate wells 0/20/60/200/600/2000 pg/ml 96 x01
EQ 6165-9601-1
ELISA Dihydrotestosterone (DHT) ELISA
antibody-coated microplate wells 0/25/100/250/500/1000/2500 pg/ml 96 x 01
EQ 6152-9601-1
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC.
1 Product manufactured by third party. Please contact your local Euroimmun representative for more information.